• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由PHF20/METTL14/HOXA13信号轴介导的表观遗传修饰调节间充质干细胞的成骨分化。

Epigenetic modification mediated by PHF20/METTL14/HOXA13 signaling axis modulates osteogenic differentiation of mesenchymal stem cells.

作者信息

Feng Weijia, Chen Ting

机构信息

Department of Pediatric Orthopaedic, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, No. 1665, Kongjiang Road, Yangpu District, Shanghai, 200092, China.

出版信息

Funct Integr Genomics. 2025 Jan 6;25(1):7. doi: 10.1007/s10142-024-01516-7.

DOI:10.1007/s10142-024-01516-7
PMID:39757292
Abstract

This study investigates the mechanism of PHF20 in osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs). BMSCs from Balb/c mouse were cultured and identified through osteogenesis, adipogenesis, and flow cytometry. After osteogenic induction, the levels of OPN and OCN in BMSCs were detected by RT-qPCR. Alizarin red staining and alkaline phosphatase (ALP) staining were used to evaluate the osteogenic differentiation ability of BMSCs. PHF20, METTL14, and HOXA13 expressions were detected by RT-qPCR and Western blot. After quantitative analysis of m6A level, RNA immunoprecipitation (RIP) was performed to measure the enrichment of IGF2BP3 or m6A on HOXA13 mRNA. HOXA13 mRNA stability was assessed after actinomycin D treatment. PHF20, METT14, and HOXA13 expressions gradually increased during osteogenic differentiation of BMSCs. Suppression of PHF20 expression repressed the osteogenic differentiation of BMSCs, mainly resulted in a decrease in OPN and OCN levels, reduced mineralization, and weakened ALP activity. Mechanistically, PHF20 elevated METTL14 expression by enhancing the enrichment of H3K4me3 on its promoter, and METTL14 strengthened HOXA13 m6A methylation to maintain HOXA13 mRNA stability through IGF2BP3. In conclusion, PHF20 elevates METTL14 expression by enhancing H3K4me3 enrichment on its promoter and enhances HOXA13 mRNA stability via IGF2BP3-mediated m6A modification, thus facilitating HOXA13 expression and eventually inducing osteogenic differentiation of BMSCs.

摘要

本研究探讨PHF20在骨髓间充质干细胞(BMSCs)成骨分化中的作用机制。培养来自Balb/c小鼠的BMSCs,并通过成骨、成脂及流式细胞术进行鉴定。成骨诱导后,采用RT-qPCR检测BMSCs中骨桥蛋白(OPN)和骨钙素(OCN)的水平。茜素红染色和碱性磷酸酶(ALP)染色用于评估BMSCs的成骨分化能力。采用RT-qPCR和蛋白质免疫印迹法检测PHF20、METTL14和HOXA13的表达。在对m6A水平进行定量分析后,进行RNA免疫沉淀(RIP)实验以检测IGF2BP3或m6A在HOXA13 mRNA上的富集情况。用放线菌素D处理后评估HOXA13 mRNA的稳定性。在BMSCs成骨分化过程中,PHF20、METT14和HOXA13的表达逐渐增加。抑制PHF20的表达可抑制BMSCs的成骨分化,主要表现为OPN和OCN水平降低、矿化减少及ALP活性减弱。机制上,PHF20通过增强H3K4me3在其启动子上的富集来提高METTL14的表达,而METTL14通过IGF2BP3增强HOXA13的m6A甲基化以维持HOXA13 mRNA的稳定性。总之,PHF20通过增强H3K4me3在其启动子上的富集来提高METTL14的表达,并通过IGF2BP3介导的m6A修饰增强HOXA13 mRNA的稳定性,从而促进HOXA13的表达并最终诱导BMSCs的成骨分化。

相似文献

1
Epigenetic modification mediated by PHF20/METTL14/HOXA13 signaling axis modulates osteogenic differentiation of mesenchymal stem cells.由PHF20/METTL14/HOXA13信号轴介导的表观遗传修饰调节间充质干细胞的成骨分化。
Funct Integr Genomics. 2025 Jan 6;25(1):7. doi: 10.1007/s10142-024-01516-7.
2
[Mechanism of ring finger protein 11 regulating Akt signaling pathway to promote osteogenic differentiation of bone marrow mesenchymal stem cells].[环状泛素连接酶11调控Akt信号通路促进骨髓间充质干细胞成骨分化的机制]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2022 Jan 15;36(1):102-110. doi: 10.7507/1002-1892.202107108.
3
Icariin upregulates methyltransferase-like 14-mediated prolyl 4-hydroxylase beta subunit m6A modification to promote osteogenic differentiation of bone marrow stem cells.淫羊藿苷通过上调甲基转移酶样蛋白 14 介导的脯氨酰 4-羟化酶β亚基 m6A 修饰促进骨髓干细胞的成骨分化。
Exp Cell Res. 2024 Jul 15;440(2):114138. doi: 10.1016/j.yexcr.2024.114138. Epub 2024 Jun 19.
4
METTL14 Regulates Osteogenesis of Bone Marrow Mesenchymal Stem Cells via Inducing Autophagy Through m6A/IGF2BPs/Beclin-1 Signal Axis.METTL14 通过 m6A/IGF2BPs/Beclin-1 信号轴诱导自噬调控骨髓间充质干细胞成骨分化。
Stem Cells Transl Med. 2022 Sep 21;11(9):987-1001. doi: 10.1093/stcltm/szac049.
5
METTL14 mediates ma modification on osteogenic proliferation and differentiation of bone marrow mesenchymal stem cells by regulating the processing of pri-miR-873.METTL14 通过调控 pri-miR-873 的加工来介导 m6A 修饰对骨髓间充质干细胞成骨增殖和分化的影响。
Mol Med Rep. 2023 Sep;28(3). doi: 10.3892/mmr.2023.13053. Epub 2023 Jul 14.
6
DLX3 regulates osteogenic differentiation of bone marrow mesenchymal stem cells via Wnt/β-catenin pathway mediated histone methylation of DKK4.DLX3 通过 Wnt/β-catenin 通路介导的 DKK4 组蛋白甲基化调控骨髓间充质干细胞的成骨分化。
Biochem Biophys Res Commun. 2019 Aug 13;516(1):171-176. doi: 10.1016/j.bbrc.2019.06.029. Epub 2019 Jun 13.
7
IGF2BP3 facilitates the osteogenic differentiation of bone marrow mesenchyml stem cells via upregulating KLK4.胰岛素样生长因子2 mRNA结合蛋白3通过上调激肽释放酶4促进骨髓间充质干细胞的成骨分化。
Connect Tissue Res. 2025 Jan;66(1):49-58. doi: 10.1080/03008207.2025.2458129. Epub 2025 Feb 23.
8
METTL3 potentiates osteogenic differentiation of bone marrow mesenchymal stem cells via IGF2BP1/m6A/RUNX2.METTL3 通过 IGF2BP1/m6A/RUNX2 促进骨髓间充质干细胞的成骨分化。
Oral Dis. 2024 Apr;30(3):1313-1321. doi: 10.1111/odi.14526. Epub 2023 Mar 13.
9
Downregulation of METTL14 improves postmenopausal osteoporosis via IGF2BP1 dependent posttranscriptional silencing of SMAD1.METTL14 的下调通过 IGF2BP1 依赖的 SMAD1 转录后沉默改善绝经后骨质疏松症。
Cell Death Dis. 2022 Nov 1;13(11):919. doi: 10.1038/s41419-022-05362-y.
10
METTL14 benefits the mesenchymal stem cells in patients with steroid-associated osteonecrosis of the femoral head by regulating the m6A level of PTPN6.METTL14 通过调控 PTPN6 的 m6A 水平促进激素性股骨头坏死患者间充质干细胞的存活。
Aging (Albany NY). 2021 Dec 15;13(24):25903-25919. doi: 10.18632/aging.203778.

本文引用的文献

1
METTL14-mediated HOXA5 mA modification alleviates osteoporosis via promoting WNK1 transcription to suppress NLRP3-dependent macrophage pyroptosis.METTL14介导的HOXA5 mA修饰通过促进WNK1转录以抑制NLRP3依赖性巨噬细胞焦亡来减轻骨质疏松症。
J Orthop Translat. 2024 Aug 27;48:190-203. doi: 10.1016/j.jot.2024.08.008. eCollection 2024 Sep.
2
METTL14-mediated methylation of SLC25A3 mitigates mitochondrial damage in osteoblasts, leading to the improvement of osteoporosis.METTL14 介导的 SLC25A3 甲基化减轻成骨细胞中的线粒体损伤,从而改善骨质疏松症。
Exp Gerontol. 2024 Sep;194:112496. doi: 10.1016/j.exger.2024.112496. Epub 2024 Jun 25.
3
Long non-coding RNA PCAT5 regulates the progression of Esophageal Squamous Cell Carcinoma via miR-4295/PHF20.
长链非编码RNA PCAT5通过miR-4295/PHF20调控食管鳞状细胞癌的进展。
Heliyon. 2023 Nov 8;9(12):e22086. doi: 10.1016/j.heliyon.2023.e22086. eCollection 2023 Dec.
4
Exosome-targeted delivery of METTL14 regulates NFATc1 m6A methylation levels to correct osteoclast-induced bone resorption.外泌体靶向递送 METTL14 调节 NFATc1 m6A 甲基化水平以纠正破骨细胞诱导的骨吸收。
Cell Death Dis. 2023 Nov 13;14(11):738. doi: 10.1038/s41419-023-06263-4.
5
METTL14 regulates chromatin bivalent domains in mouse embryonic stem cells.METTL14调节小鼠胚胎干细胞中的染色质二价结构域。
Cell Rep. 2023 Sep 26;42(9):113116. doi: 10.1016/j.celrep.2023.113116. Epub 2023 Sep 6.
6
METTL14 represses osteoclast formation to ameliorate osteoporosis via enhancing GPX4 mRNA stability.METTL14 通过增强 GPX4 mRNA 稳定性抑制破骨细胞形成从而改善骨质疏松症。
Environ Toxicol. 2023 Sep;38(9):2057-2068. doi: 10.1002/tox.23829. Epub 2023 May 17.
7
PHF20 is a Novel Prognostic Biomarker and Correlated with Immune Status in Breast Cancer.PHF20 是一种新型的乳腺癌预后生物标志物,并与免疫状态相关。
Biochem Genet. 2023 Aug;61(4):1369-1386. doi: 10.1007/s10528-022-10321-5. Epub 2023 Jan 4.
8
METTL14 upregulates TCF1 through m6A mRNA methylation to stimulate osteogenic activity in osteoporosis.METTL14通过m6A mRNA甲基化上调TCF1以刺激骨质疏松症中的成骨活性。
Hum Cell. 2023 Jan;36(1):178-194. doi: 10.1007/s13577-022-00825-y. Epub 2022 Nov 19.
9
Downregulation of METTL14 improves postmenopausal osteoporosis via IGF2BP1 dependent posttranscriptional silencing of SMAD1.METTL14 的下调通过 IGF2BP1 依赖的 SMAD1 转录后沉默改善绝经后骨质疏松症。
Cell Death Dis. 2022 Nov 1;13(11):919. doi: 10.1038/s41419-022-05362-y.
10
N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.N6-甲基腺嘌呤去甲基酶 ALKBH5 通过降低 PHF20 mRNA 甲基化来抑制结直肠癌细胞的进展。
Clin Transl Med. 2022 Aug;12(8):e940. doi: 10.1002/ctm2.940.